Jodi R Sell-grove, in Arcadia, NE - Counselor

Jodi R Sell-grove, is a Counselor - Mental Health based in Arcadia, Nebraska. Jodi R Sell-grove is licensed to practice in Nebraska (license number 13445) and her current practice location is 145 N Hastings, Arcadia, Nebraska. She can be reached at her office (for appointments etc.) via phone at (308) 789-6510.

NPI number for Jodi R Sell-grove is 1376225235 and her current mailing address is 145 N Hastings, Arcadia, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1376225235.

Contact Information

	Jodi R Sell-grove,
	145 N Hastings, Arcadia, NE 68815-6005
	(308) 789-6510
	Not Available

Healthcare Provider's Profile

Full Name	Jodi R Sell-grove
Gender	Female
Speciality	Counselor - Mental Health
Location	145 N Hastings, Arcadia, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1376225235
Provider Enumeration Date: 08/01/2023
Last Update Date: 08/01/2023

Medical Identifiers

Medical identifiers for Jodi R Sell-grove such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376225235	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	13445 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jodi R Sell-grove is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jodi R Sell-grove, 145 N Hastings, Arcadia, NE 68815-6005 Ph: (308) 789-6510	Jodi R Sell-grove, 145 N Hastings, Arcadia, NE 68815-6005 Ph: (308) 789-6510

News Archive

Only 52% of EMS practitioners have confidence in recognizing sepsis, survey finds

Today, Sepsis Alliance and the National Association of Emergency Medical Technicians released the results of their Sepsis and EMS survey.

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).

ASBM announces results of European physician survey at EuropaBio – ASEBIO Meeting

The Alliance for Safe Biologic Medicines presented results from a survey of European physicians at the "1ST EuropaBio – ASEBIO Meeting on Innovation and Biological Therapies" at the Spanish Ministry of Health, Social Services and Equality.

Study uncovers best way to cope with impostor syndrome

The impostor syndrome, a phenomenon that manifests when people feel like frauds even if they are actually capable and well-qualified, affects people both in the workplace and in the classroom.

Conatus CTS-1027 Phase 2 trial results against HCV presented at EASL meeting

Conatus Pharmaceuticals Inc. announced today 24-week interim results from a clinical trial with CTS-1027 in combination with Peginterferon Alpha-2a and ribavirin in a treatment experienced, hepatitis C virus null-responder patient population.

Jodi R Sell-grove, - Counselor in Arcadia, NE